Frontlight ResearchEarly access
Bipolar disorder trials in Japan
4 of 4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Where
- Chikugo, Chiyoda City, Fukushima, Iruma, Karatsu, Kōtō City, Kumamoto, Kure, Kurume, Sagamihara, Shibuya-ku, Tokyo, Toshima City, Yamagata, Yokohama
- Age
- 18 years to 75 years
- People
- 400 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07286175 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Where
- Bunkyo-ku, Fukuoka, Ichikawa, Iizuka, Karatsu, Kitakyushu-shi, Kochi, Kodaira, Sapporo, tabashi City, Toyoake, Wakayama, Yokohama
- Age
- 18 years to 65 years
- People
- 424 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07140913 - Phase 3Taking peopleA Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Where
- Bunkyo-ku, Fukuoka, Ichikawa, Iizuka, Iruma, Karatsu-shi, Kitakyushu, Kochi, Kodaira, Kōnan, Kumagaya, Miyazaki, Moriguchi, Obihiro, Osaka, Sakai-shi, Sapporo, tabashi City, Tokyo, Toyoake, Wakayama, Yamagata, Yokohama
- Age
- 18 years to 65 years
- People
- 450 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06929273 · EU 2024-520259-26-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Where
- Fukuoka, Ichikawa, Iruma, Karatsu-shi, Kitakyushu, Kodaira, Kōnan, Kumagaya, Miyazaki, Moriguchi, Obihiro, Osaka, Sapporo, tabashi City, Tokyo, Toyoake, Wakayama, Yamagata
- Age
- 18 years to 65 years
- People
- 274 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06951698